CureVac N.V. (CVAC)

Jan 6, 2026 - CVAC was delisted (reason: acquired by BNTX)

4.660

-0.010 (-0.21%)

Inactive · Last trade price on Jan 5, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Discovery and Development of Biotechnological Applications	535.18M	53.76M	67.42M	102.99M	48.87M
Discovery and Development of Biotechnological Applications Growth	895.54%	-20.26%	-34.54%	110.74%	180.61%
Total	535.18M	53.76M	67.42M	102.99M	48.87M
Total Growth	895.54%	-20.26%	-34.54%	110.74%	180.61%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Belgium	519.85M	47.13M	62.26M	74.30M	8.81M
Belgium Growth	1003.06%	-24.31%	-16.20%	743.43%	-
Switzerland	12.95M	5.43M	3.37M	919.00K	695.00K
Switzerland Growth	138.65%	60.98%	266.70%	32.23%	33.91%
Netherlands	2.38M	1.20M	1.79M	1.77M	2.63M
Netherlands Growth	99.08%	-33.02%	0.96%	-32.65%	-
Others	-	8.00K	-	-	-
Germany	-	-	-	26.00M	1.89M
Germany Growth	-	-	-	1279.47%	-26.88%
United States	-	-	-	-	34.85M
United States Growth	-	-	-	-	143.41%
Total	535.18M	53.76M	67.42M	102.99M	48.87M
Total Growth	895.54%	-20.26%	-34.54%	110.74%	180.61%

Source: S&P Global Market Intelligence.